BioCentury | Jul 24, 2019
Company News

July 24 Management tracks: GSK, Goldman Sachs, Ziopharm and Alkahest

...non-executive chairman to succeed Philip Hampton, effective Sept. 1. Symonds is deputy group chairman at HSBC...
BioCentury | Jul 15, 2019
Company News

Management tracks: GSK, Orphazyme, Kymera and more

...said the appointment still requires approval from banking regulators. Symonds is deputy group chairman at HSBC...
BioCentury | Nov 2, 2018
Financial News

Innovent shares rise in first day of Hong Kong trading

...at $2 billion. Underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Oct 31, 2018
Financial News

Innovent shares rise in first day of Hong Kong trading

...at $2 billion. Underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Oct 26, 2018
Financial News

Innovent raises $421M in Hong Kong IPO

...at $2 billion. Underwriters were Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Oct 24, 2018
Financial News

Innovent raises $421M in Hong Kong IPO

...at $2 billion. Underwriters were Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Aug 7, 2018
Company News

Management tracks: GSK, J&J, Denali

...hired Iain Mackay as CFO and executive director. Mackay, who is group finance director at HSBC...
BioCentury | May 4, 2018
Financial News

Ping An raises $1.1B in IPO

...Morgan, UBS, Ping An of China Securities, CCB International, CICC, CLSA, CMB International, CMS and HSBC...
BioCentury | May 3, 2018
Financial News

Ping An Good Doctor prices Hong Kong IPO

...Morgan, UBS, Ping An of China Securities, CCB International, CICC, CLSA, CMB International, CMS and HSBC...
BioCentury | Apr 27, 2018
Financial News

Ping An Healthcare sets IPO range

...Morgan, UBS, Ping An of China Securities, CCB International, CICC, CLSA, CMB International, CMS and HSBC...
Items per page:
1 - 10 of 139
BioCentury | Jul 24, 2019
Company News

July 24 Management tracks: GSK, Goldman Sachs, Ziopharm and Alkahest

...non-executive chairman to succeed Philip Hampton, effective Sept. 1. Symonds is deputy group chairman at HSBC...
BioCentury | Jul 15, 2019
Company News

Management tracks: GSK, Orphazyme, Kymera and more

...said the appointment still requires approval from banking regulators. Symonds is deputy group chairman at HSBC...
BioCentury | Nov 2, 2018
Financial News

Innovent shares rise in first day of Hong Kong trading

...at $2 billion. Underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Oct 31, 2018
Financial News

Innovent shares rise in first day of Hong Kong trading

...at $2 billion. Underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Oct 26, 2018
Financial News

Innovent raises $421M in Hong Kong IPO

...at $2 billion. Underwriters were Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Oct 24, 2018
Financial News

Innovent raises $421M in Hong Kong IPO

...at $2 billion. Underwriters were Morgan Stanley, Goldman Sachs, J.P. Morgan, CMS, Huatai Financial and HSBC...
BioCentury | Aug 7, 2018
Company News

Management tracks: GSK, J&J, Denali

...hired Iain Mackay as CFO and executive director. Mackay, who is group finance director at HSBC...
BioCentury | May 4, 2018
Financial News

Ping An raises $1.1B in IPO

...Morgan, UBS, Ping An of China Securities, CCB International, CICC, CLSA, CMB International, CMS and HSBC...
BioCentury | May 3, 2018
Financial News

Ping An Good Doctor prices Hong Kong IPO

...Morgan, UBS, Ping An of China Securities, CCB International, CICC, CLSA, CMB International, CMS and HSBC...
BioCentury | Apr 27, 2018
Financial News

Ping An Healthcare sets IPO range

...Morgan, UBS, Ping An of China Securities, CCB International, CICC, CLSA, CMB International, CMS and HSBC...
Items per page:
1 - 10 of 139